恶性疟原虫抗药性分子标记检测方法研究进展

doi:10.12140/j.issn.1000-7423.2020.04.016

中国寄生虫学与寄生虫病杂志 ›› 2020, Vol. 38 ›› Issue (4): 490-495.doi: 10.12140/j.issn.1000-7423.2020.04.016

恶性疟原虫抗药性分子标记检测方法研究进展

叶升玉¹(), 成依依², 李曼², 周红宁²^,^*()

1 昆明医科大学,昆明 650500
2 云南省寄生虫病防治所,云南省疟疾研究中心,云南省虫媒传染病防控研究重点实验室,金宁一院士工作站,普洱市江陆斌专家工作站,普洱 665000

收稿日期:2019-11-26 出版日期:2020-08-30 发布日期:2020-09-09
通讯作者: 周红宁
作者简介:叶升玉（1994-）,女,硕士研究生,主要从事虫媒传染病防治研究。E-mail：xy229104435@aliyun.
基金资助:
国家自然科学基金(U1602223);云南省科技重大专项(2017ZF007);澜湄合作专项基金(2020399)

Advances in methods for detecting drug-resistance molecular markers of Plasmodium falciparum

YE Sheng-yu¹(), CHENG Yi-yi², LI Man², ZHOU Hong-ning²^,^*()

1 Kunming Medical University, Kunming 650500, China
2 Institute of Parasitic Diseases Control, Yunnan Provincial Key Laboratory of Vector-borne Diseases Control and Research, Yunnan Provincial Center of Malaria Research, Academician Workstation of Professor Jin Ningyi, Pu’er Academician Workstation of Professor Jiang Lubin, Pu’er 665000, China

Received:2019-11-26 Online:2020-08-30 Published:2020-09-09
Contact: ZHOU Hong-ning
Supported by:
National Natural Science Foundation of China(U1602223);Science and Technology Major Project of Yunnan Province(2017ZF007);Special Project for Lancang-Mekong Cooperation(2020399)

摘要/Abstract

摘要：

疟疾是非洲和东南亚地区流行的重要热带病,严重威胁着当地居民的身体健康。随着恶性疟原虫对抗疟药物抗性的产生与蔓延,全球消除疟疾目标的实现面临着新的挑战。目前恶性疟原虫抗药性监测方法主要包括体内药效试验法、体外药敏检测法和抗性分子标记检测法,其中抗性分子标记检测法被广泛应用。本文就恶性疟原虫抗药性分子标记检测方法研究进展作一综述。

关键词: 恶性疟原虫, 抗疟疾药物, 分子标记

Abstract:

Malaria is a major tropical disease prevalent in Africa and Southeast Asia, which seriously threatens the health of local residents. The emergence and spread of Plasmodium falciparum resistance to anti-malaria drugs has challenged the realization of global malaria elimination goal. Current monitoring methods for P. falciparum drug resistance mainly include in vivo pharmacodynamic test, in vitro drug sensitivity test, and method of molecular markers of drug-resistance, of which the detection of molecular markers is widely used. This paper reviews research progress in the detection method using molecular markers for drug-resistance of P. falciparum resistance.

Key words: Plasmodium falciparum, Anti-malarial drugs, Molecular marker

中图分类号:

R382.31

叶升玉, 成依依, 李曼, 周红宁. 恶性疟原虫抗药性分子标记检测方法研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(4): 490-495.

YE Sheng-yu, CHENG Yi-yi, LI Man, ZHOU Hong-ning. Advances in methods for detecting drug-resistance molecular markers of Plasmodium falciparum[J]. Chinese Journal of Parasitology and Parasitic Diseases, 2020, 38(4): 490-495.

参考文献 48

[1]	Cowman AF, Healer J, Marapana D, et al. Malaria: biology and disease[J]. Cell, 2016,167(3):610-624.
[2]	Dondorp AM, Yeung S, White L, et al. Artemisinin resistance: current status and scenarios for containment[J]. Nat Rev Microbiol, 2010,8(4):272-280.
[3]	Xu C, Huang BC, Yan G, et al. Research progress on molecular markers of Plasmodium falciparum and drug resistance-related molecules[J]. Chin J Pathog Biol, 2016,11(12):1149-1152. (in Chinese)
[3]	( 徐超, 黄炳成, 闫歌, 等. 恶性疟原虫与耐药性相关分子遗传标记的研究进展[J]. 中国病原生物学杂志, 2016,11(12):1149-1152.)
[4]	World Health Organization. Guidelines for the treatment of malaria[J]. Geneva: WHO, 2015.
[5]	Noedl H, Se Y, Schaecher K, et al. Evidence of artemisinin-resistant malaria in western Cambodia[J]. N Engl J Med, 2008,359(24):2619-2620.
[6]	Li N, Huang YM, Cai WB, et al. Advances in the study of the sensitivity of Plasmodium falciparum to dihydroartemisinin-piperaquine[J]. Chin J Pathog Biol, 2017,12(10):1025-1027. (in Chinese)
[6]	( 李娜, 黄亚铭, 蔡文斌, 等. 恶性疟原虫对双氢青蒿素-哌喹敏感性研究进展[J]. 中国病原生物学杂志, 2017,12(10):1025-1027.)
[7]	Dondorp AM, Nosten F, Yi P, et al. Artemisinin resistance in Plasmodium falciparum malaria[J]. N Engl J Med, 2009,361(5):455-467.
[8]	Zhang YL, Pan WQ. Research progress on the resistance of Plasmodium falciparum to artemisinin[J]. Chin J Parasitol Parasit Dis, 2015,33(6):418-424. (in Chinese)
[8]	( 张逸龙, 潘卫庆. 恶性疟原虫对青蒿素产生抗性的研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2015,33(6):418-424.)
[9]	Ye R, Hu D, Zhang Y, et al. Distinctive origin of artemisinin resistant Plasmodium falciparum on the China-Myanmar border[R]. Sci Rep, 2016,6:20100.
[10]	Zhao SM, Wang MY. Global status and basic research on the resistance of Plasmodium falciparum to artemisinin[J]. Chin J Parasitol Parasit Dis, 2014,32(5):380-384. (in Chinese)
[10]	( 赵绍敏, 王满元. 恶性疟原虫对青蒿素类药物产生耐药性的全球现状和基础研究[J]. 中国寄生虫学与寄生虫病杂志, 2014,32(5):380-384.)
[11]	Ariey F, Witkowski B, Amaratunga C, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria[J]. Nature, 2014,505(7481):50-55.
[12]	Plowe CV. The evolution of drug-resistant malaria[J]. Trans R Soc Trop Med Hyg, 2009,103(Suppl 1):S11-S14.
[13]	Lin JT, Juliano JJ, Wongsrichanalai C. Drug-resistant malaria: the era of ACT[J]. Curr Infect Dis Rep, 2010,12(3):165-173.
[14]	Noedl H, Attlmayr B, Wernsdorfer WH, et al. A histidine-rich protein 2-based malaria drug sensitivity assay for field use[J]. Am J Trop Med Hyg, 2004,71(6):711-714.
[15]	Zhang MH, Lu F, Cao J, et al. Research progress on molecular markers related to drug resistance of Plasmodium falciparum[J]. Chin J Schisto Control, 2015,27(3):323-327. (in Chinese)
[15]	( 张梅花, 陆凤, 曹俊, 等. 恶性疟原虫药物抗性相关分子标记研究进展[J]. 中国血吸虫病防治杂志, 2015,27(3):323-327.)
[16]	Fidock DA, Nomura T, Talley AK, et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance[J]. Mol Cell, 2000,6(4):861-871.
[17]	Fidock DA, Eastman RT, Ward SA, et al. Recent highlights in antimalarial drug resistance and chemotherapy research[J]. Trends Parasitol, 2008,24(12):537-544.
[18]	Awasthi G, Das A. Genetics of chloroquine-resistant malaria: a haplotypic view[J]. Mem Inst Oswaldo Cruz, 2013,108(8):947-961.
[19]	Lakshmanan V, Bray PG, Verdier-Pinard D, et al. A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance[J]. EMBO J, 2005,24(13):2294-2305.
[20]	Dai TT, Lu CC, Zheng XB. Application research progress of Loop-mediated isothermal amplification in the pathogenic microorganism[J]. J Nanjing Agric Univ, 2015,38(5):695-703. (in Chinese)
[20]	( 戴婷婷, 陆辰晨, 郑小波. 环介导等温扩增技术在病原物检测上的应用研究进展[J]. 南京农业大学学报, 2015,38(5):695-703.)
[21]	Chahar M, Mishra N, Anvikar A, et al. Establishment and application of a novel isothermal amplification assay for rapid detection of chloroquine resistance (K76T) in Plasmodium falciparum[J]. Sci Rep, 2017,7:41119.
[22]	Lin LH, Huang LX, Liu GM. Value and feasibility of improved loop-mediated isothermal amplification technique in the detection of SNPs of Plasmodium falciparum resistance gene[J]. Hainan Med J, 2017,28(15):2474-2477. (in Chinese)
[22]	( 林岭海, 黄良喜, 刘光明. 改良环介导等温扩增技术在疟原虫耐药基因SNP检测中的价值及可行性[J]. 海南医学, 2017,28(15):2474-2477.)
[23]	Bashir IM, Otsyula N, Awinda G, et al. Comparison of PfHRP-2/pLDH ELISA, qPCR and microscopy for the detection of Plasmodium events and prediction of sick visits during a malaria vaccine study[J]. PLoS One, 2013,8(3):e56828.
[24]	Farcas GA, Soeller R, Zhong K, et al. Real-time polymerase chain reaction assay for the rapid detection and characterization of chloroquine-resistant Plasmodium falciparum malaria in returned travelers[J]. Clin Infect Dis, 2006,42(5):622-627.
[25]	Keen J, Farcas GA, Zhong K, et al. Real-time PCR assay for rapid detection and analysis of PfCRT haplotypes of chloroquine-resistant Plasmodium falciparum isolates from India[J]. J Clin Microbiol, 2007,45(9):2889-2893.
[26]	Rolf HA, Emmelien A, Anja R, et al. High-resolution melting analysis(HRMA): more than just sequence variant screening[J]. Hum Mutat, 2009,30(6):860-866.
[27]	Andriantsoanirina V, Lascombes V, Ratsimbasoa A, et al. Rapid detection of point mutations in Plasmodium falciparum genes associated with antimalarial drugs resistance by using high-resolution melting analysis[J]. J Microbiol Methods, 2009,78(2):165-170.
[28]	Gan LS, Loh JP. Rapid identification of chloroquine and atovaquone drug resistance in Plasmodium falciparum using high-resolution melt polymerase chain reaction[J]. Malar J, 2010,9:134.
[29]	Dong Y, Zhang ZX, Adagu IS. Detection of polymorphism of Plasmodium falciparum chloroquine resistant gene 76 Codon by nested PCR/RFLP[J]. J Pract Parasit Dis, 2001(3):104-107. (in Chinese)
[29]	( 董莹, 张再兴, Adagu IS. 套式PCR检测恶性疟原虫Pfcrt基因76号编码多态性及RFLP分析[J]. 实用寄生虫病杂志, 2001(3):104-107.)
[30]	Pholwat S, Liu J, Stroup S, et al. The malaria TaqMan array card includes 87 assays for Plasmodium falciparum drug resistance, identification of species, and genotyping in a single reaction[J]. Antimicrob Agents Chemother, 2017,61(5):e00110-e00117.
[31]	Crameri A, Marfurt J, Mugittu K, et al. Rapid microarray-based method for monitoring of all currently known single-nucleotide polymorphisms associated with parasite resistance to antimalaria drugs[J]. J Clin Microbiol, 2007,45(11):3685-3691.
[32]	Wong RP, Karunajeewa H, Mueller I, et al. Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in Papua New Guinea using an extended ligase detection reaction fluorescent microsphere assay[J]. Antimicrob Agents Chemother, 2011,55(2):798-805.
[33]	Mohon AN, Menard D, Alam MS, et al. A novel single-nucleotide polymorphism loop mediated isothermal amplification assay for detection of artemisinin-resistant Plasmodium falciparum malaria[J]. Open Forum Infect Dis, 2018, 5(4): ofy011.
[34]	Singh R, Singh DP, Savargaonkar D, et al. Evaluation of SYBR green I based visual loop-mediated isothermal amplification (LAMP) assay for genus and species-specific diagnosis of malaria in P. vivax and P. falciparum endemic regions[J]. J Vector Borne Dis, 2017,54(1):54-60.
[35]	Imai K, Tarumoto N, Misawa K, et al. A novel diagnostic method for malaria using loop-mediated isothermal amplification (LAMP) and MinION^TM nanopore sequencer[J]. BMC Infect Dis, 2017,17(1):621.
[36]	Imai K, Tarumoto N, Runtuwene LR, et al. An innovative diagnostic technology for the Codon mutation C580Y in kelch13 of Plasmodium falciparum with MinION nanopore sequencer[J]. Malar J, 2018,17(1):217.
[37]	Malpartida-Cardenas K, Rodriguez-Manzano J, Yu LS, et al. Allele-specific isothermal amplification method using unmodified self-stabilizing competitive primers[J]. Anal Chem, 2018,90(20):11972-11980.
[38]	Vachot-Ganée L, Khim N, Iannello A, et al. A novel field-based molecular assay to detect validated artemisinin-resistant k13 mutants[J]. Malar J, 2018,17(1):175.
[39]	Mens PF, van Overmeir C, Bonnet M, et al. Real-time PCR/MCA assay using fluorescence resonance energy transfer for the genotyping of resistance related DHPS-540 mutations in Plasmodium falciparum[J]. Malar J, 2008,7:48.
[40]	Cruz RE, Shokoples SE, Manage DP, et al. High-throughput genotyping of single nucleotide polymorphisms in the Plasmodium falciparum dhfr gene by asymmetric PCR and melt-curve analysis[J]. J Clin Microbiol, 2010,48(9):3081-3087.
[41]	Kamau E, Alemayehu S, Feghali KC, et al. Development of a TaqMan Allelic Discrimination assay for detection of single nucleotides polymorphisms associated with anti-malarial drug resistance[J]. Malar J, 2012,11:23.
[42]	Yongkiettrakul S, Kampeera J, Chareanchim W, et al. Simple detection of single nucleotide polymorphism in Plasmodium falciparum by SNP-LAMP assay combined with lateral flow dipstick[J]. Parasitol Int, 2017,66(1):964-971.
[43]	Daniels R, Ndiaye D, Wall M, et al. Rapid, field-deployable method for genotyping and discovery of single-nucleotide polymorphisms associated with drug resistance in Plasmodium falciparum[J]. Antimicrob Agents Chemother, 2012,56(6):2976-2986.
[44]	Bass C, Nikou D, Donnelly MJ, et al. Detection of knockdown resistance (kdr) mutations in Anopheles gambiae: a comparison of two new high-throughput assays with existing methods[J]. Malar J, 2007,6:111.
[45]	Reed MB, Saliba KJ, Caruana SR, et al. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum[J]. Nature, 2000,403(6772):906-909.
[46]	Ibraheem ZO, Abd Majid R, Noor SM, et al. Role of different pfcrt and pfmdr-1 mutations in conferring resistance to antimalaria drugs in Plasmodium falciparum[J]. Malar Res Treat, 2014,2014:950424.
[47]	Purfield A, Nelson A, Laoboonchai A, et al. A new method for detection of pfmdr1 mutations in Plasmodium falciparum DNA using real-time PCR[J]. Malar J, 2004,3:9.
[48]	Nankoberanyi S, Mbogo GW, LeClair NP, et al. Validation of the ligase detection reaction fluorescent microsphere assay for the detection of Plasmodium falciparum resistance mediating polymorphisms in Uganda[J]. Malar J, 2014,13:95.

恶性疟原虫抗药性分子标记检测方法研究进展

Advances in methods for detecting drug-resistance molecular markers of Plasmodium falciparum

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 48

相关文章 15

编辑推荐

Metrics

本文评价

[1]	李飞, 刘耀宝, 曹俊. 恶性疟原虫青蒿素耐药分子监测研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2025, 43(2): 260-268.
[2]	李素华, 纪鹏慧, 王丹, 王昊, 周瑞敏. 河南省2020年输入性恶性疟原虫Pfhrp2基因多态性分析[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(5): 664-667.
[3]	燕贺, 黄芳, 丰俊, 尹建海, 夏志贵, 曹建平. 2010—2018年云南中缅边境地区恶性疟原虫抗磺胺多辛-乙胺嘧啶药物基因多态性分析[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(2): 153-159.
[4]	周瑞敏, 纪鹏慧, 李素华, 杨成运, 刘颖, 钱丹, 邓艳, 鲁德领, 赵玉玲, 赵东阳, 张红卫. 河南省自赤道几内亚输入的恶性疟原虫抗药性基因多态性分析[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(5): 593-600.
[5]	徐少杰, 陈绅波, 陈军虎. 恶性疟原虫重复散布家族基因转录调控的研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(3): 374-379.
[6]	田斌, 廖瑜, 文岚, 肖芳, 张兵, 申晓君. 长沙市122例输入性恶性疟原虫多药抗性基因1拷贝数变异分析[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(1): 127-131.
[7]	石明丽, 肖波, 江陆斌. 恶性疟原虫var基因的表达调控机制研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(6): 719-724.
[8]	史善美, 陈军虎. 恶性疟原虫RIFIN蛋白的结构和功能研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(2): 249-255.
[9]	张苍林, 聂仁华, 徐丹, 吕高伟, 王剑, 杨亚明, 邓艳, 刘言, 周红宁. 中缅边境地区恶性疟原虫Pfcrt、Pfmdr和PfK13基因多态性与体外药物敏感性相关性的分析[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(5): 580-588.
[10]	叶升玉, 成依依, 李曼, 周红宁. 我国恶性疟原虫主要药物抗性研究[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(5): 631-636.
[11]	周水茂, 涂祖武, 杨燕, 陈芳, 贾西帅. 环介导等温扩增检测恶性疟原虫与其他疟原虫的效果评价[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(4): 423-428.
[12]	李仁清, 王小梅, 孙玉兰, 吕燕宁, 窦相峰, 王全意. 宏基因组学二代测序技术在输入性疟疾诊断中的应用[J]. 中国寄生虫学与寄生虫病杂志, 2019, 37(6): 727-729.
[13]	牟畇珊, 李璐杰, 吴银娟, 李学荣. 疟原虫青蒿素耐药分子机制探索[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(6): 636-642.
[14]	刘纯, NdoumadiambaALFRED, MounzieGouGNONDA. 胶体金恶性疟原虫检测试剂盒在非洲加蓬的临床应用[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(6): 679-680.
[15]	毛强, 裴福全, 岑咏珍, 刘梦然, 张豪, 邓卓晖. 广东省1例输血性恶性疟病例的实验室检测和溯源调查[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(5): 529-533.